Science ❯ Medicine

Clinical Trials

Drug Development Double-Blinded Randomized Clinical Trials Cancer Treatment Trials Phase III Clinical Trials Drug Safety Patient Safety Phase 2 Clinical Trials Phase III Trials

Mirum to Acquire Bluejay Therapeutics in Up to $820 Million Deal for Hepatitis D Drug

The rare-disease specialist moves to add a Phase 3 hepatitis D antibody ahead of a 2026 efficacy readout.

EU Regulator Recommends AstraZeneca’s Low-Carbon COPD Inhaler

FDA Flags Possible License Revocation for Sarepta’s Elevidys